Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
crawled date : 2022 - 04 - 08 crawled time : 18:00 save search
Kymera Therapeutics Presents Preclinical Data Highlighting Biological Superiority of MDM2 Degradation over Inhibition and Shares Profile of Clinical Candidate KT-253 at the American Association for Cancer Research (AACR) Annual Meeting 2022
Published: 2022-04-08 (Crawled : 18:00) - globenewswire.com
KYMR | $35.18 -1.48% -1.51% 380K
|
Health Technology
|
| O: 0.0%
H: 0.61%
C: -4.78%
kt-253 research preclinical therapeutics cancer pre-clinical
Genocea Presents Encouraging Initial Data from GEN-011 Phase 1/2a Trial at AACR 2022
Published: 2022-04-08 (Crawled : 18:00) - globenewswire.com
GNCA | $0.051
|
Health Technology
|
| O: 1.54%
H: 4.55%
C: -69.7%
gen-011 trial phase 1
X4 Pharmaceuticals to Present at the 2022 American Association for Cancer Research (AACR) Annual Meeting 2022
Published: 2022-04-08 (Crawled : 18:00) - globenewswire.com
XFOR | $1.28 4.06% 3.91% 2.2M
|
Health Technology
|
| O: -1.65%
H: 1.68%
C: -2.23%
research cancer
Bicycle Therapeutics to Present Interim BT8009 Phase I Clinical Trial Results at the 2022 AACR Annual Meeting
Published: 2022-04-08 (Crawled : 18:00) - biospace.com/
BCYC | $22.7 0.09% 0.09% 520K
|
Health Technology
|
| O: -0.82%
H: 34.87%
C: 25.57%
bt8009 trial therapeutics results
PathAI Announces Upcoming Presentations at the 2022 American Association for Cancer Research (AACR) Annual Meeting
Published: 2022-04-08 (Crawled : 18:00) - biospace.com/
SNYNF | News | $94.25 -2.18% 480
|
Health Technology
|
| O: 1.75%
H: 0.0%
C: 0.0%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: 2.1%
H: 0.0%
C: 0.0%
research cancer
Nykode Therapeutics announces presentation of preclinical data from its second generation Vaccibody vaccine technology at 2022 American Association for Cancer Research (AACR) Annual Meeting
Published: 2022-04-08 (Crawled : 18:00) - globenewswire.com
NKTR | News | $1.39 -2.11% -2.16% 960K
|
Health Technology
|
| O: 0.17%
H: 1.21%
C: -4.67%
research preclinical vaccine technology therapeutics presentation cancer pre-clinical
MEI Pharma Announces Two Presentations at the American Association for Cancer Research Annual Meeting 2022
Published: 2022-04-08 (Crawled : 18:00) - biospace.com/
MEIP | $3.26 -2.17% -2.22% 7.4K
|
Health Technology
|
| O: -0.82%
H: 1.43%
C: -0.88%
pharma research cancer
Nokia Corporation: Repurchase of own shares on 08.04.2022
Published: 2022-04-08 (Crawled : 18:00) - globenewswire.com
NOKBF | News | $3.6 -2.55% 400
|
Electronic Technology
| Email alert
Add to watchlist
NOK | News | $3.65 -0.82% 0.55% 13M
|
Electronic Technology
| Email alert
Add to watchlist
repurchase
Notice of AGM
Published: 2022-04-08 (Crawled : 18:00) - globenewswire.com
PPRUF | News | $340.0 37.56% 1.5K
|
Consumer Non-Durables
|
| O: 0.86%
H: 1.27%
C: -2.34%
PPRUY | News | $33.79 -0.11% 360K
|
Manufacturing
|
| O: -1.22%
H: 1.13%
C: 0.49%
BlueCity Announces Fourth Quarter and Full Year 2021 Unaudited Financial Results
Published: 2022-04-08 (Crawled : 18:00) - globenewswire.com
BLCT | $1.54 0.0%
|
Technology Services
|
| O: 4.35%
H: 0.0%
C: -4.17%
results
Oak Valley Health opens new Interventional Radiology Suite with first in Canada, innovative GE Healthcare technology
Published: 2022-04-08 (Crawled : 18:00) - globenewswire.com
GE | News | $159.19 -2.11% 0.0% 10M
|
Electronic Technology
|
| O: 0.03%
H: 0.87%
C: 0.28%
health technology
Algoma Steel Comments on Ontario’s Recently Announced Northern Energy Advantage Program
Published: 2022-04-08 (Crawled : 18:00) - globenewswire.com
ASTL | $7.74 -4.21% -4.39% 750K
|
Manufacturing
|
| O: 0.19%
H: 3.25%
C: 2.04%
energy program
Theratechnologies Presents New In Vivo TH1902 Preclinical Data Demonstrating Tumor Growth Inhibition of Human Cancer Stem-Like Cells (CD133+) in Both Triple-Negative Breast and Ovarian Cancers AACR Annual Meeting 2022
Published: 2022-04-08 (Crawled : 18:00) - globenewswire.com
THTX | $1.29 -12.78% 8.1K
|
Health Technology
|
| O: 3.4%
H: 0.0%
C: -1.23%
th1902 preclinical cancer growth pre-clinical ovarian cancer
RGC Resources, Inc. Appoints Robert Johnston to Board of Directors
Published: 2022-04-08 (Crawled : 18:00) - globenewswire.com
RGCO 4 | $20.26 1.4% 1.38% 11K
|
Utilities
| Email alert
Add to watchlist
Networking is a game of cooperation: An Interview with Joakim Löfman
Published: 2022-04-08 (Crawled : 18:00) - extremenetworks.com
EXTR 4 | $11.155 0.59% 0.58% 1.6M
|
Electronic Technology
|
| O: -0.75%
H: 0.34%
C: -1.51%
Cardiff Oncology Announces Data Showing the Combination of PARP Inhibition with Onvansertib Overcomes PARP Inhibitor Resistance in BRCA1-mutant and Wildtype Patient-Derived Xenograft Ovarian Cancer Models
Published: 2022-04-08 (Crawled : 18:00) - prnewswire.com
CRDF | $4.16 -0.24% -0.24% 340K
|
Health Services
|
| O: -0.84%
H: 4.68%
C: -1.7%
onvansertib cancer ovarian cancer
Oncolytics Biotech® Announces Positive Long-Term Survival Data from Phase 1b Glioblastoma Multiforme Trial at the AACR Annual Meeting
Published: 2022-04-08 (Crawled : 18:00) - prnewswire.com
ONCY | $1.045 -3.24% -3.35% 180K
|
Health Technology
|
| O: -0.64%
H: 7.69%
C: -0.64%
biotech trial positive phase 2b glioblastoma
Nuvalent Presents New Data Demonstrating Expanded Preclinical Activity with ROS1-Selective Inhibitor NVL-520 and ALK-Selective Inhibitor NVL-655 at AACR Annual Meeting 2022
Published: 2022-04-08 (Crawled : 18:00) - prnewswire.com
NUVL | $67.21 -0.58% -0.58% 500K
|
|
| O: -0.47%
H: 11.11%
C: 4.37%
nvl-520 preclinical pre-clinical
Xencor Presents Data from Multiple Preclinical XmAb® Cytokine Programs at the American Association for Cancer Research (AACR) Annual Meeting 2022
Published: 2022-04-08 (Crawled : 18:00) - biospace.com/
XNCR | $19.05 3.7% 3.57% 760K
|
Health Technology
|
| O: -0.6%
H: 0.46%
C: -2.39%
xmab research preclinical cancer pre-clinical
Rally House Opens in Waco for 17th Texas Location
Published: 2022-04-08 (Crawled : 18:00) - prnewswire.com
ARVL | News | $0.49 0.37% 2.5M
|
Manufacturing
|
| O: -5.94%
H: 0.0%
C: 0.0%
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.